Development of Reverse Transcription-loop-mediated Isothermal Amplification (RT-LAMP) for the Detection of the Causative Agent of COVID-19

Main Article Content

เบญจวรรณ เพชรสุขศิริ
วิพัฒน์ กล้ายุทธ
โสภา ศรีสังข์งาม
พายุ ภักดีนวน
สุปราณี บุญชู
จณิศรา ฤดีอเนกสิน

Abstract

SARS-CoV-2 virus is the causative agent of COVID-19, which is an emerging infectious disease. The disease has affected a number of infected cases and death worldwide. The current detection standard is real time RT-PCR, a nucleic acid amplification test (NAAT) used to detect the viral RNA in respiratory specimens. However, the method requires the thermocycler machine, which is complicated and costly and causes the limitation of its use in general laboratories. LAMP, an isothermal amplification, is a simple NAAT. It provides the results in a short time, which can be visualized the color change by naked eyes. This study aimed to develop RT-LAMP for SARS-CoV-2 detection by designing primers and evaluating the in silico inclusivity and cross-reactivity analyses based on microbial sequences in GISAID and NCBI databases. The reaction was optimized, and the limit of detection was determined. The results showed that the primer set targeting ORF8 exhibited > 98 % homologous to the sequence of SARS-CoV-2 and < 80 % to those of other microbes. The optimum condition of the reaction was 60 ºC for an hour, and the limit of detection for SARS-CoV-2 was 25 copies/reaction. Overall, the developed RT-LAMP was able to detect SARS-CoV-2. It requires further evaluation using clinical specimens for the determination of its applicability in COVID-19 diagnosis.

Article Details

Section
Medical Sciences
Author Biographies

เบญจวรรณ เพชรสุขศิริ

สำนักวิชาการวิทยาศาสตร์การแพทย์ กรมวิทยาศาสตร์การแพทย์ ตำบลตลาดขวัญ อำเภอเมือง จังหวัดนนทบุรี 11000

วิพัฒน์ กล้ายุทธ

สถาบันวิจัยวิทยาศาสตร์สาธารณสุข กรมวิทยาศาสตร์การแพทย์ ตำบลตลาดขวัญ อำเภอเมือง จังหวัดนนทบุรี 11000

โสภา ศรีสังข์งาม

สถาบันวิจัยวิทยาศาสตร์สาธารณสุข กรมวิทยาศาสตร์การแพทย์ ตำบลตลาดขวัญ อำเภอเมือง จังหวัดนนทบุรี 11000

พายุ ภักดีนวน

สถาบันวิจัยวิทยาศาสตร์สาธารณสุข กรมวิทยาศาสตร์การแพทย์ ตำบลตลาดขวัญ อำเภอเมือง จังหวัดนนทบุรี 11000

สุปราณี บุญชู

สถาบันวิจัยวิทยาศาสตร์สาธารณสุข กรมวิทยาศาสตร์การแพทย์ ตำบลตลาดขวัญ อำเภอเมือง จังหวัดนนทบุรี 11000

จณิศรา ฤดีอเนกสิน

สถาบันวิจัยวิทยาศาสตร์สาธารณสุข กรมวิทยาศาสตร์การแพทย์ ตำบลตลาดขวัญ อำเภอเมือง จังหวัดนนทบุรี 11000

References

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., et al., 2020, A novel corona virus from patients with pneumonia in China, 2019, N. Engl. J. Med. 382: 727-733.

Ksiazek, T.G., Erdman, D., Goldsmith, C.S., Zaki, S.R., Peret, T., Emery, S., et al., 2003, A novel coronavirus associated with severe acute respiratory syndrome, N. Engl. J. Med. 348: 1953-1966.

Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., et al., 2020, Genomic characterization and epidemiology of 2019 novel corona virus: Implications for virus origins and receptor binding, Lancet. 395: 565-574.

Okada, P., Buathong, R., Phuygun, S., Thana dachakul, T., Parnmen, S., Wongboot, W., et al., 2020, Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020, Eur. Surveill. 25(8): 2000097.

Department of Disease Control, COVID-19 Infected Situation Reports (Thailand), Available Source: https://covid19.ddc.moph.go.th/en, January 9, 2021.

Notomi, T., Okayama, H., Masubuchi, H., Yonekawa, T., Watanabe, K., Amino, N., et al., 2000, Loop-mediated isothermal amplification of DNA, Nucleic Acids Res. 28(12): E63.

Huang, W.E., Lim, B., Hsu, C.C., Xiong, D., Wu, W., Yu, Y., et al., 2020, RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2, Microb. Biotechnol. 13: 950-961.

Yu, L., Wu, S., Hao, X., Dong, X., Mao, L., Pelechano, V., et al., 2020, Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform, Clin. Chem. 66: 975-977.

Chow, F.W., Chan, T.T., Tam, A.R., Zhao, S., Yao, W., Fung, J., et al., 2020, A rapid, simple, inexpensive, and mobile colorimetric assay COVID-19-LAMP for mass on-site screening of COVID-19, Int. J. Mol. Sci. 21: 5380.

Rohaim, M.A., Clayton, E., Sahin, I., Vilela, J., Khalifa, M.E., Al-Natour, M.Q., et al., 2020, Artificial intelligence-assisted loop mediated isothermal amplification (AI-LAMP) for rapid detection of SARS-CoV-2, Viruses 12(9): 972.

Nawattanapaiboon, K., Pasomsub, E., Prombun, P., Wongbunmak, A., Jenjitwanich, A., Mahasupachai, P., et al., 2021, Colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) as a visual diagnostic platform for the detection of the emerging coronavirus SARS-CoV-2, Analyst 146: 471-477.

Baek, Y.H., Um, J., Antigua, K.J.C., Park, J.H., Kim, Y., Oh, S., et al., 2020, Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2, Emerg. Microbes. Infect. 9: 998-1007.

González-González, E., Lara-Mayorga, I.M., Rodríguez-Sánchez, I.P., Zhang, Y.S., Martínez-Chapa, S.O., Santiago, G.T., et al., 2021. Colorimetric loop-mediated isothermal amplification (LAMP) for cost-effective and quantitative detection of SARS-CoV-2: The change in color in LAMP-based assays quantitatively correlates with viral copy number, Anal Methods 13: 169-178.

Fang S., Li, K., Shen, J., Liu, S., Liu, J., Yang, L., et al., 2021. GESS: A database of global evaluation of SARS-CoV-2/hCoV-19 sequences, Nucleic Acids Res., 49(D1): D706-D14.

National Center for Biotechnology Information, GenBank, Available Source: https://www.ncbi.nlm.nih.gov/genbank, January 9, 2021.

U.S. Food and Drug Administration, Molecular Diagnostic Template for Laboratories, Available Source: https://w ww.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-au thorizations-medical-devices/vitro-diagno stics-euas, January 9, 2021.

Color Genomics, Inc., Color SARS-CoV-2 RT-LAMP Diagnostic Assay for Emergency Use Only (IFU), Available Source: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas, January 9, 2021.

Centers for Disease Control and Prevention, CDC 2019-novel Coronavirus (2019-nCoV) Real Time RT-PCR Diagnostic Panel for Emergency Use Only (IFU), Avail able Source: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas, January 9, 2021.

Akkapaiboon, P.A., Warawan, W., Thanada chakul, T, Puygun, S., Kala, S., Meechalard, W., Waichroen, S., Chittaganpitch, M. and Uppapong, B., 2020, Development of DMSc COVID-19 Real Time RT-PCR Reagent Kits, Bull. Dept. Med. Sci. 62(3): 143-154 (in Thai)

Ceraolo, C., Giorgi, F.M., 2020, Genomic variance of the 2019-nCoV coronavirus, J. Med. Virol. 92: 522-528.

Kakhki, R.K., Kakhki, M.K., Neshan,i A., 2020, COVID-19 target: A specific target for novel coronavirus detection, Gene Rep. 20: 100740.

Alouane, T., Laamarti, M., Essabbar, A., Hakmi, M., Bouricha, E.M., Chemao-Elfihri, M.W., et al., 2020, Genomic diversity and hotspot mutations in 30,983 SARS-CoV-2 genomes: Moving toward a universal vaccine for the "confined virus"?, Pathogens 9(10): 829.

Gong, Y.N., Tsao, KC., Hsiao, M.J., Huang, C.G., Huang, P.N., Huang, P.W., et al., 2020, SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East, Emerg. Microbes Infect. 9: 1457-166.

Yan, Y., Chang, L. and Wang, L., 2020, Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and counter measures, Rev. Med. Virol. 30(3): e2106.

Tomita, N., Mori, Y., Kanda, H. and Notomi, T., 2008, Loop-mediated isothermal amplification (LAMP) of gene sequences and simple visual detection of products, Nat. Protoc. 3: 877-882.

Tanne, N.A., Zhang., Y., Evans, T.C.Jr., 2015, Visual detection of isothermal nucleic acid amplification using pH-sensitive dyes, Biotechniques 58: 59-68.

Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G., et al., 2020, Detection of SARS-CoV-2 in different types of clinical specimens, JAMA 323: 1843-1844.

Kleiboeker, S., Cowden, S., Grantham, J., Nutt, J., Tyler, A., Berg, A., et al., 2020, SARS-CoV-2 viral load assessment in respiratory samples, J. Clin. Virol. 129: 104439.